Trial reportBMC geriatrics2025
Development and evaluation of a comprehensive Patient for Medication Safety (PFMS) intervention programme to improve participation in medication safety behaviours among older adults with chronic disease during hospital-to-home transition: a pilot randomized controlled trial.
Trial report in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Advanced Drug Delivery Strategies in Geriatric Patients with Polypharmacy: Integrating Pharmacokinetics, Personalized Medicine, and Emerging Technologies.Journal of clinical medicine · 2026Review
- A concept analysis of patient participation in medication safety among older adults with stroke in China: a hybrid model.BMC geriatrics · 2026Article
- Pillbox and patient-oriented manual interventions to improve medication knowledge, attitudes, and practices among older adults with multimorbidity in Shanghai, China.BMC geriatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundMedication safety management during the hospital-to-home transition for older adults with chronic disease is a key focus in public health. This study aims to develop and evaluate the feasibility and preliminary efficacy of a personalized Patient for Medication Safety (PFMS) intervention programme for older adults with chronic disease during this transition.
methodsA parallel, two-arm, randomized controlled trial was conducted. The PFMS intervention included medication reconciliation before discharge, two bedside education sessions, a portable pillbox, and six remote motivational interviews over six weeks following discharge. Both the intervention and the control groups received usual care. Feasibility was assessed using recruitment rates, retention rates, intervention adherence, data collection completion rates, satisfaction surveys, and post-intervention interviews. Outcome measures (patient participation in medication safety, health literacy, healthcare worker support, and self-efficacy) were evaluated at baseline and post-intervention. The incidence and frequency of medication discrepancies were evaluated at one and six week post-discharge. Generalized estimating equations were used to examine within-group, between-group, and time-related changes in outcomes. Thematic analysis was used to analyse the qualitative data.
resultsA total of 30 patients were enrolled in the feasibility study, with 27 completing the study. The recruitment rate was 83.3%, retention rate 90%, and intervention adherence rate 81.3%. No adverse events occurred during the intervention period. Most participants reported high satisfaction. At the end of the intervention, significant differences were observed between the two groups in patient participation in medication safety (time effect), health literacy (between-group effect), medication discrepancies (time and interaction effects), and perceived healthcare provider support (between-group, time, and interaction effects) (all P < 0.05). No significant difference was found in self-efficacy (P >0.05). Patient feedback identified: (1) facilitators for accepting the PFMS intervention: care from healthcare workers and could benefit; (2) barriers: lack of comprehension and knowledge, lack of time, concern about bothering healthcare workers, negative attitudes associated with aging, sense of self-fulfillment, and intervention fatigue; (3) suggestions for improving the PFMS programme: increased identity credibility and provision of personalized support.
conclusionsThe PFMS intervention is feasible and shows preliminary efficacy in certain aspects during the hospital-to-home transition for older adults with chronic disease. Future research should refine the intervention to better enhance patient participation in medication safety behaviours and self-efficacy.
trial registrationThis trial was retrospectively registered on 18 April 2024 in the China Clinical Trial Registry (ChiCTR2400083215).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.